Your browser doesn't support javascript.
loading
Patterns of Sequelae in Women with a History of Localized Breast Cancer: Results from the French VICAN Survey.
Delrieu, Lidia; Bouaoun, Liacine; Fatouhi, Douae El; Dumas, Elise; Bouhnik, Anne-Deborah; Noelle, Hugo; Jacquet, Emmanuelle; Hamy, Anne-Sophie; Coussy, Florence; Reyal, Fabien; Heudel, Pierre-Etienne; Bendiane, Marc-Karim; Fournier, Baptiste; Michallet, Mauricette; Fervers, Béatrice; Fagherazzi, Guy; Pérol, Olivia.
Affiliation
  • Delrieu L; Department Prevention, Cancer, Environment, Léon Bérard Cancer Center, 69008 Lyon, France.
  • Bouaoun L; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris University, 75005 Paris, France.
  • Fatouhi DE; International Agency for Research on Cancer, 69372 Lyon, France.
  • Dumas E; Center of Research in Epidemiology and Population Health, UMR 1018 Inserm, Institut Gustave Roussy, Paris-Sud Paris-Saclay University, 94807 Villejuif, France.
  • Bouhnik AD; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris University, 75005 Paris, France.
  • Noelle H; MINES ParisTech, PSL Research University, CBIO-Centre for Computational Biology, 75006 Paris, France.
  • Jacquet E; INSERM, IRD, SESSTIM, Economics & Social Sciences Applied to Health & Analysis of Medical Information, Aix Marseille University, 13007 Marseille, France.
  • Hamy AS; Department Prevention, Cancer, Environment, Léon Bérard Cancer Center, 69008 Lyon, France.
  • Coussy F; Oncology and Blood Diseases Department, University Hospital Center, Joseph Fourier University, CEDEX 9, 38043 Grenoble, France.
  • Reyal F; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris University, 75005 Paris, France.
  • Heudel PE; Department of Medical Oncology, Institut Curie, 75005 Paris, France.
  • Bendiane MK; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris University, 75005 Paris, France.
  • Fournier B; Department of Medical Oncology, Institut Curie, 75005 Paris, France.
  • Michallet M; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris University, 75005 Paris, France.
  • Fervers B; Department of Surgical Oncology, Institut Curie, University Paris, 75005 Paris, France.
  • Fagherazzi G; Department of Medical Oncology, Léon Bérard Cancer Center, 69008 Lyon, France.
  • Pérol O; INSERM, IRD, SESSTIM, Economics & Social Sciences Applied to Health & Analysis of Medical Information, Aix Marseille University, 13007 Marseille, France.
Cancers (Basel) ; 13(5)2021 Mar 08.
Article in En | MEDLINE | ID: mdl-33800346
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Guideline / Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2021 Type: Article Affiliation country: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Guideline / Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2021 Type: Article Affiliation country: France